Metraipolis › archive › dc_8db2abd516f5

Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41992834
DOI
10.1093/oncolo/oyag142
License (as archived)
solo-consultazione
Archived
2026-10-08T08:47:16.263Z
SHA-256 of the archived text
03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c
Stable URL of this page
https://metraipolis.com/documento/dc_8db2abd516f5

How to cite

Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834 — Europe PMC (en), https://europepmc.org/article/MED/41992834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8db2abd516f5 (Metraipolis archive dc_8db2abd516f5, sha256 03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c)
BibTeX
@misc{dc8db2abd516f5,
  title = {Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancer — Europe PMC PMID:41992834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41992834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8db2abd516f5; sha256 03530d678945baf4588831a8bd907aec156056d9f579f86e22978b1bd983e80c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41992834. Agents can read the archived copy with the MCP tool read_document.